BridgeBio Tshuaj
Cov khoom lag luam tau nce siab tom qab lub tuam txhab biopharmaceutical tau tshaj tawm cov txiaj ntsig zoo hauv Theem ob qhov kev sim tshuaj rau kev sim tshuaj rau achondroplasia, feem ntau hom luv luv-limbed dwarfism.
Hnub Monday, BridgeBio (ticker: BBIO) tau hais hauv xov xwm tshaj tawm tias nws qhov kev sim tshuaj Infigratinib tau pom tias muaj kev txhim kho txhua xyoo ntawm 3.03 centimeters hauv qhov hu ua qhov siab tshaj plaws, lossis nce siab, hauv kev tshawb fawb suav nrog 10 tus menyuam.
Tau qhov twg los: https://www.barrons.com/articles/bridgebio-stock-dwarfism-drug-biomarin-40cc3e70?siteid=yhoof2&yptr=yahoo